From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

A Single, Oral Dose of Ivermectin Cures Scabies

Scabies, an infestation with the mite Sarcoptes scabiei, usually responds to a single topical treatment with permethrin or lindane. In some patients, however, the infestation can be difficult to eradicate, even after repeated topical applications. In chronic care facilities, scabies can elude eradication even with the most aggessive topical treatments. Ivermectin, a widely used, orally administered, anthelmintic drug, has been reported to be an effective treatment for scabies. In this open-label study, ivermectin was given as a single oral dose (200 µg per kg of body weight) to patients with scabies.

Subjects included 11 otherwise healthy persons and 11 with HIV infection, 7 of whom had AIDS. No other scabicides had been used in the month before ivermectin therapy or during the one-month follow-up period. Of the 11 patients with uncomplicated scabies, all were cured by 4 weeks after a single dose. In the HIV-infected group, 8 patients were cured by 4 weeks after a single dose. Another 2 patients received a second dose of ivermectin 2 weeks after the first because they were still highly symptomatic; these patients cleared after a total of 4 weeks. Pruritus appeared to resolve more rapidly with ivermectin than it does with topical treatment. No adverse reactions were noted.

Comment: Ivermectin is a very appealing therapy for use in chronic care facilities, where simultaneous oral dosing of residents and personnel can be used to treat scabies outbreaks that affect symptomatic persons as well as asymptomatic carriers. Oral ivermectin also appears to be effective in the treatment of crusted (Norwegian) scabies, especially in HIV-infected patients, which in some cases is impossible to eradicate by topical therapy alone. A combination of aggressive topical therapy combined with oral ivermectin may be the optimal management for crusted scabies.

The use of oral ivermectin in the treatment of scabies is a promising advance. A single-dose, oral treatment that is cost-effective is important for public health. Ivermectin is commercially unavailable in both the United States and Canada; it should be brought to market for this indication.

— NH Shear and RA Johnson

Published in Journal Watch Dermatology September 1, 1995

Citation(s):

Meinking TL et al. The treatment of scabies with ivermectin. N Engl J Med 1995 333 26-30.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1995. Massachusetts Medical Society. All rights reserved.